While the TNF-α protein did not show significant differences between any melanoma stage compared to the control group or between stages (p > 0.05), soluble IL-6 levels were statistically different either between melanoma patients and the control group (p < 0.001) or between the two advanced stages (p < 0.05). Here, TNF is linked to melanoma.